Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Carcinoma, Basal Cell 6Carcinoma, Non-Small-Cell Lung 3Pancreatic Neoplasms 2Mycosis Fungoides 2Keratosis, Actinic 2Basal Cell Nevus Syndrome 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sezary Syndrome 1Salivary Gland Neoplasms 1Pleural Diseases 1Pain 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Mesothelioma, Malignant 1Lymphoma, T-Cell, Cutaneous 1Esthesioneuroblastoma, Olfactory 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Adenocarcinoma, Follicular 1Adenocarcinoma of Lung 1

Interventions

Iodine-131 5Sunitinib 3Magnetic Resonance Spectroscopy 3Trastuzumab 2Thyrotropin Alfa 2Gefitinib 2Fluorodeoxyglucose F18 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1trametinib 1tipifarnib 1tanespimycin 1sargramostim 1romidepsin 1pembrolizumab 1pazopanib 1motesanib diphosphate 1mercaptoundecahydrododecaborate 1lenvatinib 1dabrafenib 1cediranib 1aldesleukin 1aflibercept 1X-Rays 1Vorinostat 1Triiodothyronine 1Thalidomide 1Tamoxifen 1Surgical Procedures, Operative 1Semaxinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adenocarcinoma, Follicular × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT00470496 2022-07-25

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

Roswell Park Cancer Institute

Phase 1 Completed
15 enrolled
CNSEndocrineHead & Neck

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡